checkAd
    Belite Bio Incorporation Aktie
    44,00
     
    EUR
    -1,35 %
    -0,60 EUR
    Letzter Kurs 08:05:01 Frankfurt
    44,00
     
    EUR
    40 STK
    Geldkurs 08:05:03
    45,60
     
    EUR
    40 STK
    Briefkurs 14:03:32
    ISIN: US07782B1044 · WKN: A3DKYL · SYM: D01 · Kaiman-Inseln

    Neueste Nachrichten

    Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
    14.05.24 · globenewswire · Belite Bio Incorporation
    Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
    14.05.24 · globenewswire · Belite Bio Incorporation
    Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
    13.05.24 · globenewswire · Belite Bio Incorporation
    Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
    08.05.24 · globenewswire · Belite Bio Incorporation
    Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
    06.05.24 · globenewswire · Belite Bio Incorporation
    Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
    06.05.24 · globenewswire · Belite Bio Incorporation
    Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
    01.05.24 · globenewswire · Belite Bio Incorporation
    Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
    22.03.24 · globenewswire · Belite Bio Incorporation
    Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
    12.03.24 · globenewswire · Belite Bio Incorporation
    Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    12.03.24 · globenewswire · Belite Bio Incorporation
    Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
    06.03.24 · globenewswire · Belite Bio Incorporation
    Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
    04.03.24 · globenewswire · Belite Bio Incorporation